

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.50387917 |
| 2 | sarcomere organization (GO:0045214) | 6.90200708 |
| 3 | cardiac myofibril assembly (GO:0055003) | 6.33991151 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.04346816 |
| 5 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.02319293 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.66653681 |
| 7 | cardiac muscle contraction (GO:0060048) | 5.60349281 |
| 8 | myofibril assembly (GO:0030239) | 5.50023500 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.46493031 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.42434351 |
| 11 | carnitine shuttle (GO:0006853) | 5.41631425 |
| 12 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.38009200 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.36468384 |
| 14 | regulation of actin filament-based movement (GO:1903115) | 5.33805983 |
| 15 | regulation of relaxation of muscle (GO:1901077) | 5.33473593 |
| 16 | lysine catabolic process (GO:0006554) | 5.27403243 |
| 17 | lysine metabolic process (GO:0006553) | 5.27403243 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.27271818 |
| 19 | NADH metabolic process (GO:0006734) | 5.25562237 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.17363688 |
| 21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.16498605 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15580081 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07850884 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 5.07133135 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.99063916 |
| 26 | tricarboxylic acid metabolic process (GO:0072350) | 4.97818437 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.81757439 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.81114146 |
| 29 | regulation of coenzyme metabolic process (GO:0051196) | 4.79339883 |
| 30 | regulation of cofactor metabolic process (GO:0051193) | 4.79339883 |
| 31 | positive thymic T cell selection (GO:0045059) | 4.78929257 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.75011587 |
| 33 | negative regulation of cell killing (GO:0031342) | 4.75011587 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.73792356 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.70343711 |
| 36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.63749320 |
| 37 | carnitine transport (GO:0015879) | 4.63536986 |
| 38 | amino-acid betaine transport (GO:0015838) | 4.63536986 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.62728301 |
| 40 | oxidative phosphorylation (GO:0006119) | 4.60811634 |
| 41 | cardiac muscle cell development (GO:0055013) | 4.58900405 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 4.53434077 |
| 43 | fatty acid beta-oxidation (GO:0006635) | 4.51764878 |
| 44 | carnitine transmembrane transport (GO:1902603) | 4.51087607 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44835013 |
| 46 | actin-myosin filament sliding (GO:0033275) | 4.39624415 |
| 47 | muscle filament sliding (GO:0030049) | 4.39624415 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.37731865 |
| 49 | cardiac cell development (GO:0055006) | 4.33634347 |
| 50 | regulation of skeletal muscle contraction (GO:0014819) | 4.31106805 |
| 51 | creatine metabolic process (GO:0006600) | 4.29306376 |
| 52 | adult heart development (GO:0007512) | 4.23465456 |
| 53 | actomyosin structure organization (GO:0031032) | 4.20731786 |
| 54 | cardiac muscle hypertrophy (GO:0003300) | 4.18464769 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 4.17882385 |
| 56 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.16546779 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16327865 |
| 58 | valine metabolic process (GO:0006573) | 4.14806621 |
| 59 | cell communication by electrical coupling (GO:0010644) | 4.13000411 |
| 60 | striated muscle contraction (GO:0006941) | 4.12917628 |
| 61 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.08465921 |
| 62 | quaternary ammonium group transport (GO:0015697) | 4.07137861 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 4.05769281 |
| 64 | regulation of sequestering of triglyceride (GO:0010889) | 4.05127593 |
| 65 | relaxation of cardiac muscle (GO:0055119) | 4.02250662 |
| 66 | regulation of sarcomere organization (GO:0060297) | 4.01230093 |
| 67 | regulation of the force of heart contraction (GO:0002026) | 3.99848634 |
| 68 | cell communication involved in cardiac conduction (GO:0086065) | 3.96907649 |
| 69 | striated muscle hypertrophy (GO:0014897) | 3.95265437 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 3.94924277 |
| 71 | succinate metabolic process (GO:0006105) | 3.94689494 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.94410995 |
| 73 | respiratory electron transport chain (GO:0022904) | 3.92313315 |
| 74 | regulation of membrane repolarization (GO:0060306) | 3.90913805 |
| 75 | positive T cell selection (GO:0043368) | 3.88801631 |
| 76 | heart trabecula formation (GO:0060347) | 3.88238951 |
| 77 | regulation of sulfur metabolic process (GO:0042762) | 3.87770875 |
| 78 | thymic T cell selection (GO:0045061) | 3.87435246 |
| 79 | regulation of cell communication by electrical coupling (GO:0010649) | 3.85792763 |
| 80 | branched-chain amino acid metabolic process (GO:0009081) | 3.84543865 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 3.83673421 |
| 82 | electron transport chain (GO:0022900) | 3.81712656 |
| 83 | negative T cell selection (GO:0043383) | 3.80762892 |
| 84 | regulation of striated muscle contraction (GO:0006942) | 3.79594089 |
| 85 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.73500357 |
| 86 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.73244500 |
| 87 | plasma membrane repair (GO:0001778) | 3.72849834 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.69685656 |
| 89 | ATP synthesis coupled proton transport (GO:0015986) | 3.65136364 |
| 90 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.65136364 |
| 91 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.63912231 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62932111 |
| 93 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.62198277 |
| 94 | detection of bacterium (GO:0016045) | 3.61300337 |
| 95 | biotin metabolic process (GO:0006768) | 3.59322782 |
| 96 | T cell selection (GO:0045058) | 3.59242983 |
| 97 | cellular response to zinc ion (GO:0071294) | 3.58792123 |
| 98 | fatty acid catabolic process (GO:0009062) | 3.56383468 |
| 99 | lipid oxidation (GO:0034440) | 3.54774281 |
| 100 | carnitine metabolic process (GO:0009437) | 3.54765706 |
| 101 | fatty acid oxidation (GO:0019395) | 3.54479939 |
| 102 | actin-mediated cell contraction (GO:0070252) | 3.54266926 |
| 103 | regulation of B cell differentiation (GO:0045577) | 3.54087890 |
| 104 | detection of other organism (GO:0098543) | 3.47772247 |
| 105 | heart contraction (GO:0060047) | 3.47683306 |
| 106 | heart process (GO:0003015) | 3.47683306 |
| 107 | muscle hypertrophy (GO:0014896) | 3.46576545 |
| 108 | positive regulation of granulocyte differentiation (GO:0030854) | 3.46449883 |
| 109 | oxaloacetate metabolic process (GO:0006107) | 3.44404556 |
| 110 | immunoglobulin mediated immune response (GO:0016064) | 3.44340470 |
| 111 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.40453376 |
| 112 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38367781 |
| 113 | potassium ion import (GO:0010107) | 3.34858563 |
| 114 | gas transport (GO:0015669) | 3.29507042 |
| 115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.28964325 |
| 116 | muscle tissue morphogenesis (GO:0060415) | 3.28506806 |
| 117 | Peyers patch development (GO:0048541) | 3.27289206 |
| 118 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.27289206 |
| 119 | regulation of ATPase activity (GO:0043462) | 3.24694406 |
| 120 | regulation of ATP catabolic process (GO:1903289) | 3.24694406 |
| 121 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.24072930 |
| 122 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23069827 |
| 123 | regulation of cardiac muscle contraction (GO:0055117) | 3.20829109 |
| 124 | cardiac muscle cell action potential (GO:0086001) | 3.20347471 |
| 125 | germinal center formation (GO:0002467) | 3.17827183 |
| 126 | ubiquinone biosynthetic process (GO:0006744) | 3.12858834 |
| 127 | quinone biosynthetic process (GO:1901663) | 3.12858834 |
| 128 | regulation of granulocyte differentiation (GO:0030852) | 3.10717961 |
| 129 | modulation by symbiont of host immune response (GO:0052553) | 3.09576763 |
| 130 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09576763 |
| 131 | modulation by symbiont of host defense response (GO:0052031) | 3.09576763 |
| 132 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09576763 |
| 133 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09576763 |
| 134 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09576763 |
| 135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07529092 |
| 136 | negative regulation of heart growth (GO:0061117) | 3.02438611 |
| 137 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.02438611 |
| 138 | leukocyte aggregation (GO:0070486) | 3.00943786 |
| 139 | regulation of mast cell degranulation (GO:0043304) | 2.95752042 |
| 140 | neutrophil activation involved in immune response (GO:0002283) | 2.93994057 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88232237 |
| 142 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82863086 |
| 143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.79691943 |
| 144 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78851732 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.75306105 |
| 146 | regulation of leukocyte degranulation (GO:0043300) | 2.74897886 |
| 147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.71212824 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70126869 |
| 149 | megakaryocyte development (GO:0035855) | 2.68797465 |
| 150 | regulation of interleukin-4 production (GO:0032673) | 2.65866889 |
| 151 | response to interleukin-15 (GO:0070672) | 2.64886818 |
| 152 | definitive hemopoiesis (GO:0060216) | 2.63171857 |
| 153 | detection of external biotic stimulus (GO:0098581) | 2.62707892 |
| 154 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62645506 |
| 155 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62044325 |
| 156 | T cell migration (GO:0072678) | 2.62036820 |
| 157 | cellular extravasation (GO:0045123) | 2.60142641 |
| 158 | regulation of tolerance induction (GO:0002643) | 2.59761251 |
| 159 | positive regulation of type 2 immune response (GO:0002830) | 2.59115593 |
| 160 | regulation of antigen processing and presentation (GO:0002577) | 2.58959009 |
| 161 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58224695 |
| 162 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.57672970 |
| 163 | response to peptidoglycan (GO:0032494) | 2.57635734 |
| 164 | response to muramyl dipeptide (GO:0032495) | 2.57209257 |
| 165 | response to type I interferon (GO:0034340) | 2.56303716 |
| 166 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56267454 |
| 167 | tolerance induction (GO:0002507) | 2.54072083 |
| 168 | cellular response to type I interferon (GO:0071357) | 2.53871648 |
| 169 | type I interferon signaling pathway (GO:0060337) | 2.53871648 |
| 170 | mannose metabolic process (GO:0006013) | 2.53330645 |
| 171 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.53162153 |
| 172 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52723019 |
| 173 | regulation of necroptotic process (GO:0060544) | 2.52446482 |
| 174 | regulation of germinal center formation (GO:0002634) | 2.51718404 |
| 175 | regulation of ARF protein signal transduction (GO:0032012) | 2.50991163 |
| 176 | hemoglobin metabolic process (GO:0020027) | 2.50833677 |
| 177 | actin filament polymerization (GO:0030041) | 2.50152037 |
| 178 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49005098 |
| 179 | response to host immune response (GO:0052572) | 2.49005098 |
| 180 | positive regulation of interleukin-4 production (GO:0032753) | 2.46627263 |
| 181 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.46156916 |
| 182 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.45986006 |
| 183 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.45009372 |
| 184 | B cell mediated immunity (GO:0019724) | 2.42540807 |
| 185 | oxygen transport (GO:0015671) | 2.42306070 |
| 186 | defense response to protozoan (GO:0042832) | 2.38813118 |
| 187 | regulation of regulated secretory pathway (GO:1903305) | 2.36134639 |
| 188 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.35661339 |
| 189 | negative regulation of innate immune response (GO:0045824) | 2.34833680 |
| 190 | response to host (GO:0075136) | 2.33370159 |
| 191 | response to host defenses (GO:0052200) | 2.33370159 |
| 192 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33370159 |
| 193 | positive regulation of tolerance induction (GO:0002645) | 2.32962557 |
| 194 | mature B cell differentiation involved in immune response (GO:0002313) | 2.32343050 |
| 195 | response to protozoan (GO:0001562) | 2.32332427 |
| 196 | regulation of necrotic cell death (GO:0010939) | 2.32140997 |
| 197 | negative regulation of myotube differentiation (GO:0010832) | 2.31660577 |
| 198 | lymphocyte homeostasis (GO:0002260) | 2.31429660 |
| 199 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.30663804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.28562533 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07757608 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.68269327 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.36240643 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.04139317 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.04139317 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93439793 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.70234909 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68805802 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34353700 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32033760 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.31110779 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.29399665 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.28857944 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27025454 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24414448 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.12967415 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11449732 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00643194 |
| 20 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.98157648 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95175289 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95070311 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.90037242 |
| 24 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88245991 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87512910 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85493250 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85319606 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85080801 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83368317 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82398838 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80432949 |
| 32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75421480 |
| 33 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.75029111 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74457737 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.73654727 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.71769472 |
| 37 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.69599907 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68989207 |
| 39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.68447645 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64591470 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63735696 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61928225 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61846579 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60981661 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59709650 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59531811 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58322878 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58141126 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57872180 |
| 50 | GATA2_19941826_ChIP-Seq_K562_Human | 1.57314841 |
| 51 | * MYB_26560356_Chip-Seq_TH1_Human | 1.57259591 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56996809 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55533853 |
| 54 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.51942677 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51838207 |
| 56 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49547225 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48282638 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47535380 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44027416 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43821304 |
| 61 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43698667 |
| 62 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43523468 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43328255 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41648956 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41073512 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39430981 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38559594 |
| 68 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37657322 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37495499 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37342708 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34843294 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32647801 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32385438 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31623953 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27227219 |
| 76 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27007150 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.26618933 |
| 78 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26448469 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25217824 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22770923 |
| 81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21548488 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21277519 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20714638 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20610152 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20108131 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18204815 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17008618 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16937276 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16762905 |
| 90 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16003367 |
| 91 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14551029 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.14527960 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13824351 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12978732 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12161130 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12030866 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11971340 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11080880 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10610362 |
| 100 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10457473 |
| 101 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10154209 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09689031 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08992407 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08761387 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.06308809 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06231830 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06065724 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05997123 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05923067 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05387242 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05155186 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04021247 |
| 113 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03806612 |
| 114 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03349641 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02687023 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02387431 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02309651 |
| 118 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02264081 |
| 119 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01813786 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99978385 |
| 121 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99690005 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99516200 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99080331 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98782067 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97443526 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95339135 |
| 127 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95047344 |
| 128 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94734346 |
| 129 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93864700 |
| 130 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93653983 |
| 131 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93470617 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 0.92989779 |
| 133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92053644 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89845415 |
| 135 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89773649 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89055366 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.88810654 |
| 138 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88427900 |
| 139 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88044384 |
| 140 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87699457 |
| 141 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87025820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.71998665 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.39065292 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.78697807 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.63292412 |
| 5 | MP0000751_myopathy | 4.14941772 |
| 6 | MP0005330_cardiomyopathy | 3.56212949 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.45467295 |
| 8 | MP0004130_abnormal_muscle_cell | 3.07896881 |
| 9 | MP0003436_decreased_susceptibility_to | 3.04137181 |
| 10 | MP0000749_muscle_degeneration | 2.99862936 |
| 11 | MP0003303_peritoneal_inflammation | 2.80698775 |
| 12 | MP0002972_abnormal_cardiac_muscle | 2.77930862 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.69562725 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.67363199 |
| 15 | MP0002132_abnormal_respiratory_system | 2.59669465 |
| 16 | MP0004484_altered_response_of | 2.52681270 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.52546226 |
| 18 | MP0003724_increased_susceptibility_to | 2.49212990 |
| 19 | MP0010630_abnormal_cardiac_muscle | 2.46549880 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.46113160 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.40178179 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.40178179 |
| 23 | MP0005025_abnormal_response_to | 2.32884085 |
| 24 | MP0004043_abnormal_pH_regulation | 2.30074566 |
| 25 | MP0005671_abnormal_response_to | 2.25664730 |
| 26 | MP0009278_abnormal_bone_marrow | 2.24371131 |
| 27 | MP0005620_abnormal_muscle_contractility | 2.19460866 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.19329318 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 2.13577093 |
| 30 | MP0005451_abnormal_body_composition | 2.13169588 |
| 31 | MP0005666_abnormal_adipose_tissue | 2.11587815 |
| 32 | * MP0006036_abnormal_mitochondrial_physio | 2.10533547 |
| 33 | MP0003183_abnormal_peptide_metabolism | 2.08862285 |
| 34 | MP0005670_abnormal_white_adipose | 2.02733869 |
| 35 | MP0002419_abnormal_innate_immunity | 2.01674584 |
| 36 | MP0002420_abnormal_adaptive_immunity | 2.01656352 |
| 37 | MP0003172_abnormal_lysosome_physiology | 2.00760769 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.98510411 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.98116563 |
| 40 | MP0003828_pulmonary_edema | 1.97804615 |
| 41 | MP0001819_abnormal_immune_cell | 1.97613579 |
| 42 | MP0002723_abnormal_immune_serum | 1.96959501 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.96795202 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.96795202 |
| 45 | MP0004147_increased_porphyrin_level | 1.94447624 |
| 46 | MP0006138_congestive_heart_failure | 1.89498376 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.88003648 |
| 48 | MP0002398_abnormal_bone_marrow | 1.87603313 |
| 49 | MP0002269_muscular_atrophy | 1.84713792 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71708938 |
| 51 | MP0009785_altered_susceptibility_to | 1.67121313 |
| 52 | MP0000747_muscle_weakness | 1.66962089 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.64980956 |
| 54 | MP0000716_abnormal_immune_system | 1.64790104 |
| 55 | MP0004085_abnormal_heartbeat | 1.64753139 |
| 56 | MP0004947_skin_inflammation | 1.54320573 |
| 57 | MP0004510_myositis | 1.49895161 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.48556473 |
| 59 | MP0002722_abnormal_immune_system | 1.48281991 |
| 60 | MP0005369_muscle_phenotype | 1.48111111 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.46888881 |
| 62 | MP0005310_abnormal_salivary_gland | 1.46715118 |
| 63 | MP0002405_respiratory_system_inflammati | 1.43859972 |
| 64 | MP0000343_altered_response_to | 1.43458267 |
| 65 | MP0004233_abnormal_muscle_weight | 1.42965280 |
| 66 | MP0002009_preneoplasia | 1.42366218 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.40444551 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.39754271 |
| 69 | MP0008260_abnormal_autophagy | 1.38717987 |
| 70 | MP0002429_abnormal_blood_cell | 1.37413666 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.33384513 |
| 72 | MP0005165_increased_susceptibility_to | 1.32862004 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.32237866 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.30668342 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.29821709 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.27022926 |
| 77 | MP0002127_abnormal_cardiovascular_syste | 1.26371703 |
| 78 | MP0005332_abnormal_amino_acid | 1.24567481 |
| 79 | MP0001853_heart_inflammation | 1.24232482 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.21816411 |
| 81 | MP0006082_CNS_inflammation | 1.18906689 |
| 82 | MP0001765_abnormal_ion_homeostasis | 1.18873218 |
| 83 | MP0003300_gastrointestinal_ulcer | 1.15906388 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.14735438 |
| 85 | MP0003279_aneurysm | 1.11988685 |
| 86 | MP0001873_stomach_inflammation | 1.08348737 |
| 87 | MP0000266_abnormal_heart_morphology | 1.07895108 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.06714417 |
| 89 | MP0002006_tumorigenesis | 1.04941391 |
| 90 | MP0008469_abnormal_protein_level | 1.03855638 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.02623198 |
| 92 | MP0001851_eye_inflammation | 1.00624215 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.98963200 |
| 94 | MP0003075_altered_response_to | 0.98289396 |
| 95 | MP0004381_abnormal_hair_follicle | 0.98199229 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.97912927 |
| 97 | MP0003690_abnormal_glial_cell | 0.97542602 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97537541 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.96743684 |
| 100 | MP0006054_spinal_hemorrhage | 0.96696318 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.95955798 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.95488298 |
| 103 | MP0001958_emphysema | 0.95358269 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.95147564 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91086374 |
| 106 | MP0001664_abnormal_digestion | 0.89936107 |
| 107 | MP0000681_abnormal_thyroid_gland | 0.89474316 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.89156284 |
| 109 | MP0003879_abnormal_hair_cell | 0.88387424 |
| 110 | MP0005377_hearing/vestibular/ear_phenot | 0.86258435 |
| 111 | MP0003878_abnormal_ear_physiology | 0.86258435 |
| 112 | MP0002933_joint_inflammation | 0.86109620 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.84984469 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.83706394 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.83503854 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.79960551 |
| 117 | MP0003329_amyloid_beta_deposits | 0.78130628 |
| 118 | MP0002971_abnormal_brown_adipose | 0.76807871 |
| 119 | MP0001756_abnormal_urination | 0.76640379 |
| 120 | MP0005083_abnormal_biliary_tract | 0.76262155 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.75587903 |
| 122 | MP0000604_amyloidosis | 0.75025297 |
| 123 | MP0008995_early_reproductive_senescence | 0.74513759 |
| 124 | MP0002128_abnormal_blood_circulation | 0.73679119 |
| 125 | MP0008569_lethality_at_weaning | 0.73654729 |
| 126 | MP0000249_abnormal_blood_vessel | 0.73620402 |
| 127 | MP0005410_abnormal_fertilization | 0.72777165 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.72648701 |
| 129 | MP0009840_abnormal_foam_cell | 0.72219922 |
| 130 | MP0008004_abnormal_stomach_pH | 0.70164007 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.69199800 |
| 132 | MP0008874_decreased_physiological_sensi | 0.68659499 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.68421603 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.67667769 |
| 135 | MP0000490_abnormal_crypts_of | 0.67622326 |
| 136 | MP0000678_abnormal_parathyroid_gland | 0.65992239 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.65119852 |
| 138 | MP0010329_abnormal_lipoprotein_level | 0.64926562 |
| 139 | MP0002396_abnormal_hematopoietic_system | 0.64018007 |
| 140 | MP0003191_abnormal_cellular_cholesterol | 0.61349416 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.59910745 |
| 142 | MP0003186_abnormal_redox_activity | 0.57004106 |
| 143 | MP0000685_abnormal_immune_system | 0.53580101 |
| 144 | MP0003866_abnormal_defecation | 0.53234763 |
| 145 | MP0005360_urolithiasis | 0.52551212 |
| 146 | MP0000767_abnormal_smooth_muscle | 0.51821658 |
| 147 | MP0010155_abnormal_intestine_physiology | 0.50055053 |
| 148 | * MP0002078_abnormal_glucose_homeostasis | 0.50007212 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.49879952 |
| 150 | MP0001663_abnormal_digestive_system | 0.49497607 |
| 151 | MP0005387_immune_system_phenotype | 0.49344216 |
| 152 | MP0001790_abnormal_immune_system | 0.49344216 |
| 153 | MP0009115_abnormal_fat_cell | 0.49150361 |
| 154 | MP0000003_abnormal_adipose_tissue | 0.48867715 |
| 155 | MP0003763_abnormal_thymus_physiology | 0.48040686 |
| 156 | * MP0005266_abnormal_metabolism | 0.46882858 |
| 157 | MP0001835_abnormal_antigen_presentation | 0.46753792 |
| 158 | MP0002138_abnormal_hepatobiliary_system | 0.46451616 |
| 159 | MP0003045_fibrosis | 0.46222045 |
| 160 | MP0005334_abnormal_fat_pad | 0.45896403 |
| 161 | MP0005166_decreased_susceptibility_to | 0.44084816 |
| 162 | MP0001784_abnormal_fluid_regulation | 0.43763761 |
| 163 | * MP0002118_abnormal_lipid_homeostasis | 0.43188381 |
| 164 | MP0001800_abnormal_humoral_immune | 0.42480319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.23585686 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.01082814 |
| 3 | Atrial fibrillation (HP:0005110) | 4.97088454 |
| 4 | Myoglobinuria (HP:0002913) | 4.92111153 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.77376888 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.67848196 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 4.63409501 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.56846520 |
| 9 | Supraventricular tachycardia (HP:0004755) | 4.52184160 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.46959880 |
| 11 | Supraventricular arrhythmia (HP:0005115) | 4.41321156 |
| 12 | Bundle branch block (HP:0011710) | 4.38303545 |
| 13 | Lipoatrophy (HP:0100578) | 4.31224673 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.29099006 |
| 15 | Muscle fiber splitting (HP:0003555) | 4.23401868 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 4.19697008 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.18484863 |
| 18 | Syncope (HP:0001279) | 4.04128134 |
| 19 | Palpitations (HP:0001962) | 4.01452430 |
| 20 | Ketoacidosis (HP:0001993) | 3.90866581 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.86673271 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.82488755 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 3.81183843 |
| 24 | Heart block (HP:0012722) | 3.79684736 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.79570962 |
| 26 | Atrioventricular block (HP:0001678) | 3.71967530 |
| 27 | Rhabdomyolysis (HP:0003201) | 3.62785415 |
| 28 | Meningitis (HP:0001287) | 3.59279531 |
| 29 | Hyperglycinuria (HP:0003108) | 3.57881859 |
| 30 | Prolonged QT interval (HP:0001657) | 3.54323700 |
| 31 | Hyporeflexia of lower limbs (HP:0002600) | 3.53813774 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50423762 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 3.48528924 |
| 34 | Subaortic stenosis (HP:0001682) | 3.42242936 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.42242936 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.40029909 |
| 37 | Hepatic necrosis (HP:0002605) | 3.35946070 |
| 38 | Cellulitis (HP:0100658) | 3.35888852 |
| 39 | Ventricular arrhythmia (HP:0004308) | 3.30597605 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30044003 |
| 41 | Recurrent fungal infections (HP:0002841) | 3.29941261 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.26875091 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.26875091 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 3.15106710 |
| 45 | Increased IgE level (HP:0003212) | 3.14717098 |
| 46 | Recurrent viral infections (HP:0004429) | 3.14247606 |
| 47 | Myositis (HP:0100614) | 3.12866464 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 3.11036566 |
| 49 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.06779388 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04724669 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03496095 |
| 52 | Obstructive lung disease (HP:0006536) | 3.03496095 |
| 53 | Ventricular fibrillation (HP:0001663) | 3.02595339 |
| 54 | Nasal polyposis (HP:0100582) | 2.98537518 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.96774416 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.96121540 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.96016254 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.91919703 |
| 59 | Ketosis (HP:0001946) | 2.88672264 |
| 60 | Difficulty running (HP:0009046) | 2.88448000 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87204731 |
| 62 | Increased connective tissue (HP:0009025) | 2.85275918 |
| 63 | EMG: myopathic abnormalities (HP:0003458) | 2.81880464 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.81194171 |
| 65 | Hepatocellular necrosis (HP:0001404) | 2.79357453 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.79156892 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.78271209 |
| 68 | Hyperalaninemia (HP:0003348) | 2.78271209 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.78271209 |
| 70 | Conjunctival hamartoma (HP:0100780) | 2.77991356 |
| 71 | Abnormality of glycine metabolism (HP:0010895) | 2.76850307 |
| 72 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76850307 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.75381952 |
| 74 | Recurrent sinusitis (HP:0011108) | 2.74377816 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 2.72721146 |
| 76 | Recurrent bronchitis (HP:0002837) | 2.70950045 |
| 77 | Petechiae (HP:0000967) | 2.69966818 |
| 78 | Abnormality of B cell number (HP:0010975) | 2.66587422 |
| 79 | Epistaxis (HP:0000421) | 2.64974592 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.62414743 |
| 81 | Granulocytopenia (HP:0001913) | 2.61814041 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.60103519 |
| 83 | Gout (HP:0001997) | 2.58793588 |
| 84 | Acute necrotizing encephalopathy (HP:0006965) | 2.58422760 |
| 85 | Encephalitis (HP:0002383) | 2.57561940 |
| 86 | Acute encephalopathy (HP:0006846) | 2.57547299 |
| 87 | Nausea (HP:0002018) | 2.53510260 |
| 88 | B lymphocytopenia (HP:0010976) | 2.52471722 |
| 89 | Vasculitis (HP:0002633) | 2.48616485 |
| 90 | Purpura (HP:0000979) | 2.46643681 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45705218 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45705218 |
| 93 | Hyperammonemia (HP:0001987) | 2.45374787 |
| 94 | Chronic otitis media (HP:0000389) | 2.44092151 |
| 95 | Recurrent skin infections (HP:0001581) | 2.43971092 |
| 96 | Abnormality of the fingertips (HP:0001211) | 2.43477975 |
| 97 | Gingivitis (HP:0000230) | 2.43336739 |
| 98 | Limb-girdle muscle atrophy (HP:0003797) | 2.43123618 |
| 99 | Abnormal EKG (HP:0003115) | 2.43039744 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.40863777 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.33847414 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33845671 |
| 103 | Chest pain (HP:0100749) | 2.33501692 |
| 104 | Papilledema (HP:0001085) | 2.33442514 |
| 105 | Polycythemia (HP:0001901) | 2.33276925 |
| 106 | Orchitis (HP:0100796) | 2.32130608 |
| 107 | Lactic acidosis (HP:0003128) | 2.27857225 |
| 108 | Osteomyelitis (HP:0002754) | 2.27592568 |
| 109 | Abnormality of T cells (HP:0002843) | 2.27461195 |
| 110 | Cerebral edema (HP:0002181) | 2.27289352 |
| 111 | Facial diplegia (HP:0001349) | 2.26672983 |
| 112 | Myotonia (HP:0002486) | 2.26251498 |
| 113 | T lymphocytopenia (HP:0005403) | 2.24954783 |
| 114 | Esophageal neoplasm (HP:0100751) | 2.24323784 |
| 115 | Neoplasm of head and neck (HP:0012288) | 2.24323784 |
| 116 | Polyuria (HP:0000103) | 2.23122309 |
| 117 | Abnormal urine output (HP:0012590) | 2.21988190 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21976996 |
| 119 | Respiratory failure (HP:0002878) | 2.21888371 |
| 120 | Left ventricular hypertrophy (HP:0001712) | 2.20950977 |
| 121 | Verrucae (HP:0200043) | 2.19167314 |
| 122 | Papilloma (HP:0012740) | 2.19167314 |
| 123 | Mitochondrial inheritance (HP:0001427) | 2.19093789 |
| 124 | Progressive macrocephaly (HP:0004481) | 2.18169956 |
| 125 | Hyperactive renin-angiotensin system (HP:0000841) | 2.17966965 |
| 126 | Increased CSF lactate (HP:0002490) | 2.17942521 |
| 127 | Stomatitis (HP:0010280) | 2.17350188 |
| 128 | Seborrheic dermatitis (HP:0001051) | 2.16884585 |
| 129 | Hamartoma of the eye (HP:0010568) | 2.15427573 |
| 130 | Hypochromic anemia (HP:0001931) | 2.15418146 |
| 131 | Ankle clonus (HP:0011448) | 2.15187392 |
| 132 | Palmoplantar keratoderma (HP:0000982) | 2.14173617 |
| 133 | Abnormality of renal excretion (HP:0011036) | 2.13594059 |
| 134 | Recurrent otitis media (HP:0000403) | 2.13093977 |
| 135 | Diaphragmatic weakness (HP:0009113) | 2.12956270 |
| 136 | Testicular atrophy (HP:0000029) | 2.12758679 |
| 137 | Increased circulating renin level (HP:0000848) | 2.10566141 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10507048 |
| 139 | Abnormality of T cell number (HP:0011839) | 2.10210438 |
| 140 | Gingival bleeding (HP:0000225) | 2.09061719 |
| 141 | Metabolic acidosis (HP:0001942) | 2.09034882 |
| 142 | Slow saccadic eye movements (HP:0000514) | 2.06823985 |
| 143 | Chronic sinusitis (HP:0011109) | 2.06676972 |
| 144 | Optic neuritis (HP:0100653) | 2.05863124 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 2.05863124 |
| 146 | Pustule (HP:0200039) | 2.05112867 |
| 147 | Abnormality of T cell physiology (HP:0011840) | 2.04308808 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04297800 |
| 149 | Chronic diarrhea (HP:0002028) | 2.03812754 |
| 150 | Hypokalemic alkalosis (HP:0001949) | 2.02026737 |
| 151 | Absent/shortened dynein arms (HP:0200106) | 2.02008384 |
| 152 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02008384 |
| 153 | Multiple enchondromatosis (HP:0005701) | 2.02004516 |
| 154 | Athetosis (HP:0002305) | 2.01802781 |
| 155 | Increased purine levels (HP:0004368) | 2.01479849 |
| 156 | Hyperuricemia (HP:0002149) | 2.01479849 |
| 157 | Malnutrition (HP:0004395) | 2.01360558 |
| 158 | Autoimmune hemolytic anemia (HP:0001890) | 2.00276639 |
| 159 | Eosinophilia (HP:0001880) | 2.00141288 |
| 160 | Bronchitis (HP:0012387) | 1.99849365 |
| 161 | Difficulty climbing stairs (HP:0003551) | 1.98607796 |
| 162 | Leukocytosis (HP:0001974) | 1.98429692 |
| 163 | Ragged-red muscle fibers (HP:0003200) | 1.97579896 |
| 164 | Severe combined immunodeficiency (HP:0004430) | 1.97116693 |
| 165 | Sepsis (HP:0100806) | 1.96507883 |
| 166 | Mesangial abnormality (HP:0001966) | 1.96443744 |
| 167 | Distal lower limb muscle weakness (HP:0009053) | 1.96308380 |
| 168 | Urticaria (HP:0001025) | 1.96161342 |
| 169 | Cerebral palsy (HP:0100021) | 1.95283524 |
| 170 | Vomiting (HP:0002013) | 1.94876808 |
| 171 | Sudden cardiac death (HP:0001645) | 1.94586498 |
| 172 | Testicular neoplasm (HP:0010788) | 1.94080468 |
| 173 | Metabolic alkalosis (HP:0200114) | 1.92767730 |
| 174 | Gastrointestinal stroma tumor (HP:0100723) | 1.92149329 |
| 175 | Hypertensive crisis (HP:0100735) | 1.91834607 |
| 176 | Colitis (HP:0002583) | 1.91133083 |
| 177 | Reticulocytosis (HP:0001923) | 1.90929563 |
| 178 | Agammaglobulinemia (HP:0004432) | 1.90335930 |
| 179 | Systemic lupus erythematosus (HP:0002725) | 1.88060651 |
| 180 | Growth hormone excess (HP:0000845) | 1.86453159 |
| 181 | Abnormality of iron homeostasis (HP:0011031) | 1.85414085 |
| 182 | Skin rash (HP:0000988) | 1.84407610 |
| 183 | Increased serum ferritin (HP:0003281) | 1.84406788 |
| 184 | Viral hepatitis (HP:0006562) | 1.82484124 |
| 185 | Bronchiectasis (HP:0002110) | 1.81132059 |
| 186 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.80445646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.97991265 |
| 2 | TTN | 4.63283457 |
| 3 | PRPF4B | 3.99350956 |
| 4 | RIPK4 | 3.73180748 |
| 5 | TRIB3 | 3.69133155 |
| 6 | PDK3 | 3.41490885 |
| 7 | PDK4 | 3.41490885 |
| 8 | PHKG1 | 3.34612004 |
| 9 | PHKG2 | 3.34612004 |
| 10 | BCKDK | 3.07914289 |
| 11 | PKN2 | 2.90463875 |
| 12 | MYLK | 2.68827493 |
| 13 | WNK4 | 2.54775158 |
| 14 | TNK2 | 2.51632495 |
| 15 | PDK2 | 2.21844733 |
| 16 | DMPK | 2.01317920 |
| 17 | FES | 1.97523887 |
| 18 | MAP3K13 | 1.85179693 |
| 19 | OBSCN | 1.82686617 |
| 20 | NEK1 | 1.82574930 |
| 21 | MAP3K11 | 1.77479915 |
| 22 | PIK3CA | 1.75793770 |
| 23 | TESK2 | 1.73325264 |
| 24 | EEF2K | 1.69826633 |
| 25 | BLK | 1.68948895 |
| 26 | MAP4K1 | 1.68385919 |
| 27 | PINK1 | 1.63199820 |
| 28 | LRRK2 | 1.62096256 |
| 29 | MAP3K10 | 1.62009026 |
| 30 | TGFBR2 | 1.59228878 |
| 31 | SMG1 | 1.56582217 |
| 32 | TIE1 | 1.52713357 |
| 33 | MARK2 | 1.42049362 |
| 34 | TAOK1 | 1.38456126 |
| 35 | STK24 | 1.36971546 |
| 36 | STK39 | 1.35653407 |
| 37 | MAPK12 | 1.35613870 |
| 38 | ERN1 | 1.34310598 |
| 39 | STK4 | 1.33932746 |
| 40 | SIK1 | 1.25701006 |
| 41 | STK10 | 1.24974570 |
| 42 | IRAK4 | 1.22471752 |
| 43 | IKBKE | 1.20929931 |
| 44 | TAOK3 | 1.19889896 |
| 45 | MAP3K7 | 1.19056283 |
| 46 | MAP3K1 | 1.15073214 |
| 47 | MAPK15 | 1.13884427 |
| 48 | TYK2 | 1.11664935 |
| 49 | GRK7 | 1.10081545 |
| 50 | PRKD1 | 1.05898267 |
| 51 | HCK | 1.04422094 |
| 52 | TXK | 1.03960487 |
| 53 | GRK6 | 1.02880517 |
| 54 | NME2 | 1.02120763 |
| 55 | TAOK2 | 1.01002903 |
| 56 | SIK2 | 0.98046913 |
| 57 | MAPKAPK3 | 0.97804600 |
| 58 | LYN | 0.96737959 |
| 59 | OXSR1 | 0.96383639 |
| 60 | MAP2K2 | 0.95773682 |
| 61 | CAMKK1 | 0.94378705 |
| 62 | LCK | 0.93278774 |
| 63 | MUSK | 0.93107977 |
| 64 | HIPK2 | 0.91829497 |
| 65 | MAP3K3 | 0.89033633 |
| 66 | MST4 | 0.89001217 |
| 67 | PRKAA1 | 0.87635305 |
| 68 | CAMK1D | 0.87197344 |
| 69 | MAP3K14 | 0.85614351 |
| 70 | PAK3 | 0.84242944 |
| 71 | PRKAA2 | 0.84182677 |
| 72 | TEC | 0.79952536 |
| 73 | PRKD2 | 0.79448813 |
| 74 | KSR2 | 0.77624258 |
| 75 | JAK1 | 0.76952191 |
| 76 | ILK | 0.75355903 |
| 77 | RIPK1 | 0.72690035 |
| 78 | DYRK1B | 0.72653745 |
| 79 | SGK3 | 0.72425547 |
| 80 | PTK6 | 0.70405410 |
| 81 | FLT3 | 0.69280740 |
| 82 | RET | 0.66764190 |
| 83 | PDGFRA | 0.65886726 |
| 84 | CDC42BPA | 0.65239186 |
| 85 | MAP2K3 | 0.64933009 |
| 86 | EPHB1 | 0.62068119 |
| 87 | MAP2K6 | 0.61751390 |
| 88 | MATK | 0.61231539 |
| 89 | DAPK2 | 0.60922042 |
| 90 | PDK1 | 0.60848070 |
| 91 | IKBKB | 0.60062074 |
| 92 | MAPK11 | 0.58233358 |
| 93 | RPS6KA2 | 0.57495005 |
| 94 | STK38 | 0.57136726 |
| 95 | BMPR2 | 0.57067673 |
| 96 | PRKD3 | 0.56952413 |
| 97 | PDPK1 | 0.56713875 |
| 98 | TESK1 | 0.56555788 |
| 99 | WNK1 | 0.56319016 |
| 100 | TRPM7 | 0.56245444 |
| 101 | CAMK4 | 0.55271077 |
| 102 | MAPK4 | 0.53100717 |
| 103 | FYN | 0.52537228 |
| 104 | WNK3 | 0.52468348 |
| 105 | ROCK1 | 0.52418057 |
| 106 | SCYL2 | 0.52247769 |
| 107 | CAMK2D | 0.50116812 |
| 108 | CSF1R | 0.50093915 |
| 109 | CDK4 | 0.49021243 |
| 110 | UHMK1 | 0.48347380 |
| 111 | FGFR3 | 0.47801419 |
| 112 | JAK2 | 0.47612464 |
| 113 | PIM1 | 0.47147447 |
| 114 | SYK | 0.46168811 |
| 115 | RPS6KL1 | 0.45866341 |
| 116 | RPS6KC1 | 0.45866341 |
| 117 | FGFR4 | 0.45657545 |
| 118 | BTK | 0.45611125 |
| 119 | MARK3 | 0.45056592 |
| 120 | PIK3CG | 0.43715704 |
| 121 | CAMK1G | 0.41790472 |
| 122 | MAPK3 | 0.41544979 |
| 123 | ITK | 0.40249712 |
| 124 | RPS6KA6 | 0.39786586 |
| 125 | SGK2 | 0.39260167 |
| 126 | STK11 | 0.39040787 |
| 127 | TBK1 | 0.38798405 |
| 128 | AKT2 | 0.38450399 |
| 129 | IRAK3 | 0.38130217 |
| 130 | JAK3 | 0.37804881 |
| 131 | KDR | 0.37477106 |
| 132 | CDK12 | 0.37230292 |
| 133 | CAMK1 | 0.36325709 |
| 134 | CSK | 0.36286690 |
| 135 | PRKCH | 0.36078715 |
| 136 | NEK6 | 0.35302013 |
| 137 | ZAP70 | 0.35057461 |
| 138 | PRKCQ | 0.34481839 |
| 139 | ICK | 0.33880482 |
| 140 | RPS6KB2 | 0.33421969 |
| 141 | MAPK7 | 0.33104586 |
| 142 | PDGFRB | 0.33020985 |
| 143 | NEK9 | 0.31413898 |
| 144 | STK38L | 0.30783773 |
| 145 | PRKACG | 0.29198966 |
| 146 | KIT | 0.27566191 |
| 147 | RPS6KA1 | 0.27429853 |
| 148 | ROCK2 | 0.26835326 |
| 149 | PRKACB | 0.23152044 |
| 150 | MAP3K5 | 0.22415751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.38595620 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.68758231 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.78618206 |
| 4 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.75028584 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.12456298 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.94193727 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.89285827 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.59302371 |
| 9 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.54593183 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.51673734 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46145866 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.42387075 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.31407014 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.29090547 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27643897 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.24984414 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02359263 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.95978695 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92698741 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91377568 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90664106 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.87546674 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.82780675 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82403947 |
| 25 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78266349 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.68831159 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67124991 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64503839 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52643457 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52219108 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.49607724 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46542082 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41798965 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.40796656 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37876338 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.35591041 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32318537 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30835348 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27196547 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.22246237 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21749280 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.17055132 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14384512 |
| 44 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.12831928 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10043311 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09353658 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08353746 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01992641 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01578322 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00784081 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00638159 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00019418 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.99565261 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97319098 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96499959 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.95246099 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.95237337 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94670664 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92269442 |
| 60 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91158544 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89220976 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85660566 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85087678 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83340091 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82695873 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82333036 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81240271 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80068962 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79847921 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79466836 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78651877 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78466803 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78364921 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77115707 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.75800064 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72815831 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.72366696 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71707336 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71524236 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71382631 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69042493 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68951502 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65553593 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65493881 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65492004 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63377028 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.63286778 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62065527 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62064569 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61537117 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61038687 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60827939 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60719316 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60059426 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.59769702 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58958803 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57828179 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57207043 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56945224 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.56590911 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56390898 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56088912 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54864477 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54840698 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54109873 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52921350 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.52759714 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51646575 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51612540 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49869105 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49755340 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49136175 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48302067 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.46779116 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46777672 |
| 116 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45885617 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44942130 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44467607 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42233146 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41869625 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40622863 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40364966 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39169946 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39161996 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.39051477 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36361976 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36109109 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34099223 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34044293 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.32285444 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30490434 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29716300 |
| 133 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.29539387 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27845210 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27616458 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.27006807 |
| 137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26892626 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26579835 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26144959 |
| 140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.24436484 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.23790574 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22849457 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22587197 |
| 144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22068282 |
| 145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21962013 |
| 146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21816518 |
| 147 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.20502190 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19774399 |
| 149 | Adherens junction_Homo sapiens_hsa04520 | 0.19113950 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18890226 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17122786 |
| 152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17056358 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.15713458 |
| 154 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14997491 |
| 155 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14647552 |
| 156 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.14449226 |
| 157 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.13634957 |
| 158 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13124186 |
| 159 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12203353 |

